Family summary
Historical shortage references are available across related Hydroxyzine pamoate presentations from multiple manufacturers.
- 0 current shortage context pages.
- 6 historical shortage context pages.
- 2 manufacturers represented.
Hydroxyzine pamoate - Drug Shortage Information
Public shortage context is available across 6 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
hydroxyzine pamoate 50 mg / 1 Capsule 100 Capsule - NDC 00185-0615-01Sandoz Inc | 100 Capsulehydroxyzine pamoate 50 mg / 1 Capsule 500 Capsule - NDC 00185-0615-05Sandoz Inc | 500 Capsulehydroxyzine pamoate 25 mg / 1 Capsule 100 Capsule - NDC 00185-0674-01Sandoz Inc | 100 Capsulehydroxyzine pamoate 25 mg / 1 Capsule 500 Capsule - NDC 00185-0674-05Sandoz Inc | 500 CapsuleHydroxyzine Pamoate 25 mg / 1 Capsule 100 Capsule - NDC 00115-1803-01Amneal Pharmaceuticals of New York LLC | 100 Capsule
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.